News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
May, 2024
May 2024
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Marc Eid: Stellar talk by Jacob Berchuck during Transatlantic exchange 2024
Photo taken from Marc Eid/X
Apr 18, 2024, 17:03

Marc Eid: Stellar talk by Jacob Berchuck during Transatlantic exchange 2024

Marc Eid, Postdoctoral research fellow in Medical Oncology at the Dana-Farber Cancer Institute, shared on X:

“Stellar talk by Jacob Berchuck during Transatlantic Exchange 2024. Leveraging epigenomic liquid biopsy for the non-invasive detection of aggressive variants of prostate and lung cancer.”

Source: Marc Eid/X

cancer Dana-Farber Cancer Institute Jacob Berchuck liquid biopsy Lung cancer Marc Eid medical oncology OncoDaily Oncology prostate cancer Transatlantic Exchange 2024 AMP
Blog
May 1, 2024, 14:46
Naveen Pemmaraju: Celebrating the launch of RUSH MD Anderson Cancer Center
Insight
May 1, 2024, 14:22
Danielle Bitterman: LLMs might help burnout by drafting responses to patient portal messages in EHRs
Opinion
May 1, 2024, 13:41
Sara Tolaney: Such an important question addressed in the Alliance A011502 study
Blog
May 1, 2024, 13:27
Jennifer Marks: Reconsideration of IO in the inpatient setting
Blog
May 1, 2024, 13:08
Chadi Nabhan: The amazing Sanam Loghavi will be in Chicago at the HemOnc Pulse LIVE
Blog
May 1, 2024, 13:01
Courtney Bugler: Quality of life implications last much longer than most doctors admit
Blog
May 1, 2024, 12:57
Chris Boshoff: Pfizer in ASCO24
Blog
May 1, 2024, 12:36
Partha Basu: IARC announced the launch of the Cancer Screening in Five Continents Training
Blog
May 1, 2024, 12:28
Ken Herrmann: 4 days of everything you need to know about advanced prostate cancer
Insight
May 1, 2024, 12:17
David R. Liu: The first prime editing clinical trial has been cleared by U.S. FDA to begin
Blog
May 1, 2024, 12:12
FDA has cleared Prime Medicine's PM359 for the treatment of chronic granulomatous disease
Blog
May 1, 2024, 12:05
Paolo Tarantino: Refresher for the current and upcoming definitions of HER2 in breast oncology